Dannex Ayrton Starwin Limited 2022 Interim Results For The Third Quarter

Dannex Ayrton Starwin Limited (DASL.gh) Q32022 Interim Report

By Published On: November 1, 2022TYPE: Interim ReportsYear: 2022Period: Q3Country: GhanaSector: Pharmaceuticals

Dannex Ayrton Starwin Limited (DASL.gh) listed on the Ghana Stock Exchange under the Pharmaceuticals sector has released it’s 2022 interim results for the third quarter.

For more information about Dannex Ayrton Starwin Limited (DASL.gh) reports, abridged reports, interim earnings results and earnings presentations visit the Dannex Ayrton Starwin Limited (DASL.gh) company page on AfricanFinancials.

Indicative Share Trading Liquidity

The total indicative share trading liquidity for Dannex Ayrton Starwin Limited (DASL.gh) in the past 12 months, as of 1st October 2022, is US$1.51K (GHS10.26K). An average of US$126 (GHS855) per month.

Dannex Ayrton Starwin Limited 2022 interim results for the third quarter

Company Profile

Dannex Ayrton Starwin Limited is a pharmaceutical company in Ghana, listed on the Ghana Exchange, that supplies anti-hypertensives, hematinics, dermatological, antibiotics, deworming, pain killers and anti-inflammatory drugs. On 19th December, 2018, the Boards of Dannex Ltd, Ayrton Drug Manufacturing Ltd and Starwin Products Ltd announced that they had agreed to the terms of a recommended merger of the three companies to be effected by way of a Ghanaian Scheme of Amalgamation under Section 231 of the Companies Act.